Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05648266Completed
Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by University Medical Center Hamburg-Eppendorf. Primary endpoint: Numeric Rating Scale at 48 hours. Started Apr 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05648266.